


| Gilead signs agreement with Pakistan’s Ferozsons to produce COVID-19 drug remdesivir Updated 29 minutes ago |
|
ISLAMABAD: US-based firm Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in South Asia including Ferozsons Laboratories of Pakistan to further expand the supply of remdesivir. “The agreements allow the companies – Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd.
Posted: 2020-05-13 20:35:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.